IMAX Corporation (NYSE:IMAX – Get Free Report) shares gapped up prior to trading on Thursday after the company announced better than expected quarterly earnings. The stock had previously closed at $39.30, but opened at $41.75. IMAX shares last traded at $44.7410, with a volume of 1,021,196 shares changing hands.
The company reported $0.43 EPS for the quarter, topping the consensus estimate of $0.30 by $0.13. IMAX had a net margin of 9.84% and a return on equity of 15.65%. The company had revenue of $102.84 million during the quarter, compared to analysts’ expectations of $96.09 million. During the same quarter in the previous year, the business posted $0.26 EPS. The firm’s revenue was up 12.2% on a year-over-year basis.
IMAX News Summary
Here are the key news stories impacting IMAX this week:
- Positive Sentiment: IMAX reported better-than-expected second-quarter results, with EPS and revenue both topping Wall Street estimates, while management reaffirmed full-year guidance and highlighted margin expansion and network growth. IMAX Corporation Reports Second Quarter 2026 Results
- Positive Sentiment: Strong box-office traction for The Odyssey is boosting confidence that IMAX can sustain higher ticket sales and premium-screen utilization, with reports suggesting the film could be a transformational release for the company. The Odyssey is cleaning up for IMAX. Expect the momentum to continue
- Positive Sentiment: Analysts turned more bullish after earnings, with JPMorgan, Wells Fargo, Barrington, and Wedbush all raising price targets, and Wedbush reiterating Outperform on expectations for a stronger film pipeline, market-share gains, and international expansion. IMAX price target boosted by Wedbush on growth outlook
- Positive Sentiment: Investor attention is also being reinforced by unusual call-option activity and multiple stories about sold-out IMAX 70mm showings, signaling strong near-term demand sentiment around the stock. Imax’s CEO says it’s time to hike prices as tickets to ‘The Odyssey’ resell for $1,000
- Neutral Sentiment: IMAX disclosed a new regulatory risk tied to geopolitical, trade, and other global expansion challenges, which could matter over time but does not appear to be driving near-term trading. IMAX Confronts Rising Geopolitical, Regulatory and Trade Risks Threatening Global Expansion
Wall Street Analysts Forecast Growth
Check Out Our Latest Stock Analysis on IMAX
Insider Activity at IMAX
In other news, CEO Richard L. Gelfond sold 8,943 shares of the business’s stock in a transaction dated Monday, April 27th. The stock was sold at an average price of $37.33, for a total value of $333,842.19. Following the completion of the sale, the chief executive officer directly owned 765,002 shares of the company’s stock, valued at approximately $28,557,524.66. The trade was a 1.16% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Company insiders own 20.55% of the company’s stock.
Institutional Inflows and Outflows
Hedge funds have recently added to or reduced their stakes in the company. AQR Capital Management LLC lifted its stake in IMAX by 47.9% in the first quarter. AQR Capital Management LLC now owns 56,348 shares of the company’s stock valued at $1,485,000 after buying an additional 18,238 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its position in shares of IMAX by 4.5% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 25,486 shares of the company’s stock worth $672,000 after acquiring an additional 1,091 shares during the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC grew its position in shares of IMAX by 7.9% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 159,714 shares of the company’s stock worth $4,208,000 after acquiring an additional 11,736 shares during the last quarter. Creative Planning increased its holdings in shares of IMAX by 84.1% in the 2nd quarter. Creative Planning now owns 16,081 shares of the company’s stock valued at $450,000 after acquiring an additional 7,344 shares during the period. Finally, Norges Bank acquired a new position in shares of IMAX in the 2nd quarter valued at $709,000. Hedge funds and other institutional investors own 93.51% of the company’s stock.
IMAX Stock Performance
The firm’s 50-day moving average is $39.99 and its 200 day moving average is $38.03. The stock has a market cap of $2.38 billion, a PE ratio of 60.02, a P/E/G ratio of 1.61 and a beta of 0.37.
IMAX Company Profile
IMAX Corporation is a global leader in immersive entertainment technologies, specializing in the design, manufacture and distribution of high-resolution cameras, projectors, and proprietary software solutions that enhance both film production and theatrical exhibition. The company licenses its premium large-format system to theatre owners and filmmakers around the world, enabling audiences to experience movies with greater clarity, scale and sound fidelity. IMAX also offers turnkey theatre development services, assisting cinema operators with auditorium design, installation and custom branding to optimize the customer experience.
Founded in 1967 and headquartered in Mississauga, Ontario, IMAX has built a reputation for pioneering film-format innovations, including its patented dual 15-perforation, 70-millimeter projection system.
Recommended Stories
- Five stocks we like better than IMAX
- AMD and Cerbras Create A New Blueprint For Hardware
- Intel Earnings Reveal Whether the Chip Selloff Created a Buy
- CrowdStrike’s Cerebras Deal Puts Its AI Security Strategy to the Test
- Plugging In: How Kinder Morgan Powers Up Profits
Receive News & Ratings for IMAX Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IMAX and related companies with MarketBeat.com's FREE daily email newsletter.
